HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC labeling

This article was originally published in The Rose Sheet

Executive Summary

Agenda for OTC labeling working group meeting Sept. 17 includes discussions on columns, alternative packaging and the exemption process. The meeting will be the fourth in a series of at least five meetings to be held between FDA and industry on the final rule (1"The Rose Sheet" Aug. 23, p. 5). The topic of the Aug. 24 meeting was the effect of the reg on product trade dress (2see related stories, pp. 3-5). An agenda for a working group scheduled for Nov. 1 has not yet been set

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007074

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel